Tiblio
Sign Up

AHG

Akso Health Group ADR
NASDAQHEALTHCAREMEDICAL DISTRIBUTION

Key Statistics

Market Cap
$1.25B
P/E Ratio
—
EPS
$-0.03
Beta
-1.00
52W High
$2.50
52W Low
$1.10
50-Day MA
$1.47
200-Day MA
$1.65
Dividend Yield
—
Profit Margin
-135.00%
Forward P/E
—
PEG Ratio
—

About Akso Health Group ADR

Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.

Official WebsiteChinaFY End: March

Fundamentals

Revenue (TTM)$13.83M
Gross Profit (TTM)-11,315
EBITDA$-1.63M
Operating Margin-37.50%
Return on Equity-9.85%
Return on Assets-1.24%
Revenue/Share (TTM)$0.02
Book Value$0.21
Price-to-Book6.91
Price-to-Sales (TTM)90.43
EV/Revenue90.44
EV/EBITDA-0.39
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-12.90%
Shares Outstanding$854.04M
Float$854.05M
% Insiders0.00%
% Institutions0.03%

Historical Volatility

HV 10-Day
68.81%
HV 20-Day
58.83%
HV 30-Day
80.45%
HV 60-Day
78.37%
HV Rank
51.2%

Volatility is currently contracting

Latest News

AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology

QINGDAO, China, April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development program. The Company is establishing the foundational R&D infrastructure necessary to develop and commercialize BCI technology, which it believes represents one of the most transformative and high-value technology frontiers of the 21st century.

PRNewsWire4/27/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AHG and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCNVONovo Nordisk A/STMOThermo Fisher Scientific IncAMGNAmgen IncABTAbbott LaboratoriesGILDGilead Sciences Inc
View all HEALTHCARE stocks →
Data last updated: 7/29/2026